Comparison

Inavolisib European Partner

€1,900.00
Excl. VAT
Item no. M11405-50mg
Manufacturer AbMole
CASRN 2060571-02-8
Amount 50mg
Category
Type Inhibitors
Specific against other
Purity >98%
Formula C18H19F2N5O4
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias GDC-0077; RG6114;RO-7113755
Available
Bioactivity information
GDC-0077 (RG6114) is a potential best-in-class, orally selective PI3Kα inhibitor (IC50=0.038 nM). GDC-0077 (RG6114) exerts its activity by binding to the ATP binding site of PI3K, thereby inhibiting the phosphorylation of PIP2 to PIP3. GDC-0077 (RG6114) is more selective for mutants compared to wild-type PI3Kα. It can trigger the degradation of mutation-producing PIK3α.
mw
407, 37
solubility
DMSO ≥ 60 mg/mL

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
Listprice: €1,900.00
Price: €1,900.00
available

Delivery expected until 9/11/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close